House passes bill that reauthorises the FDA’s paediatric priority voucher pathway
Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.
Business & Regulation
UK and US strike “landmark” zero-tariff pharma deal
Novo Nordisk latest outlook trim shows “quick momentum loss”
Tidmarsh’s FDA exit marks latest high-profile jockeying at US agencies
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
Massive sales for weight loss drugs spur Eli Lilly’s Q3
FDA rejects Regeneron’s pre-filled Eylea HD syringes amid filling facility woes
Novartis Q3: new drugs step up as generics squeeze Entresto
